Search

Your search keyword '"Dowling, James E."' showing total 95 results

Search Constraints

Start Over You searched for: Author "Dowling, James E." Remove constraint Author: "Dowling, James E."
95 results on '"Dowling, James E."'

Search Results

1. The Fibronectin-Binding Integrins System as a Contributor to PAH Pathogenesis

3. Optimization of a Series of Novel, Potent and Selective Macrocyclic SYK Inhibitors

4. Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors

5. Improving HIV Surveillance Data by Using the ATra Black Box System to Assist Regional Deduplication Activities

6. Abstract 10717: Role of Integrin Signaling in Pulmonary Arterial Hypertension

7. Abstract 1559: Inhibition of integrin αvβ8 enhances immune checkpoint induced anti-tumor immunity by acting across immunologic synapse in syngeneic models of breast cancer

8. Optimization of a series of potent, selective and orally bioavailable SYK inhibitors

10. Integrin alphaVbeta1 inhibition ameliorates liver fibrosis in mice

11. Synthesis of 2,4-diamino-5,6,7,8,9,10-hexahydro-5,9-methanopyrimido[4,5-b]azocine

12. Replacement of the 1'4,'-phenylene region in 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF) by 4,5,6,7-tetrahydrobenzo(c)thiophene and 4,5,6,7-tetrahydroisobenzofuran nuclei

14. Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265PDiffuse Large B-Cell Lymphoma

15. Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay

16. Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma

17. Cover Picture: Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2 (ChemMedChem 12/2017)

18. Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2

19. Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors

20. Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo

22. Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma.

24. Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening

25. Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity

26. Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo

27. Abstract 2353: Novel inhibitors of PIM-1, PIM-2, and PIM-3 protein kinases: medicinal chemistry leading to AZD1208.

30. Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization

33. Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists

40. Index.

48. Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists

49. Rotational matched spatial filter for biological pattern recognition

Catalog

Books, media, physical & digital resources